Generation of a human induced pluripotent stem cell line UGENTi002-A from an arrhythmogenic cardiomyopathy patient carrying the c.817C>T DSP heterozygous variant and isogenic control using CRISPR/Cas9 editing

Stem Cell Res. 2024 Dec:81:103537. doi: 10.1016/j.scr.2024.103537. Epub 2024 Aug 22.

Abstract

Arrhythmogenic cardiomyopathy is a severe genetic heart muscle disease characterized by fibro-fatty replacement of the myocardium. Pathogenic variants causal for this disease are mainly located in desmosomal genes, including desmoplakin (DSP). Renal epithelial cells were isolated from a patient carrying the heterozygous c.817C>T (p.Q273*, nonsense) pathogenic variant in DSP, and subsequently reprogrammed using the Cytotune®-iPS 2.0 Sendai Reprogramming Kit. An isogenic control line was generated using CRISPR/Cas9 genome editing. The resulting induced pluripotent stem cell lines were characterized and displayed the required traits for in vitro disease modeling.

MeSH terms

  • Arrhythmogenic Right Ventricular Dysplasia / genetics
  • Arrhythmogenic Right Ventricular Dysplasia / pathology
  • CRISPR-Cas Systems* / genetics
  • Cell Line
  • Desmoplakins* / genetics
  • Desmoplakins* / metabolism
  • Gene Editing*
  • Heterozygote
  • Humans
  • Induced Pluripotent Stem Cells* / metabolism

Substances

  • Desmoplakins
  • DSP protein, human